Type 2 Diabetes & Obesity
Type 2 diabetes and obesity are twin epidemics that are growing at alarming rates around the world. Type 2 diabetes, the most common form of diabetes, affects more than 21 million Americans and more than 200 million people worldwide. Type 2 diabetes can lead to significant health problems including cardiovascular disease, retinopathy, neuropathy, and nephropathy.
Obesity is even more prevalent. More than 70 million Americans are obese, and obesity is one of the risk factors for type 2 diabetes. The encouraging news is that surgical weight loss procedures such as gastric bypass surgery can result in resolution of type 2 diabetes and significant weight loss. Less encouraging is the fact that despite the results that may be anticipated, many patients choose not to undergo invasive surgery out of fear.
There is a need to address the growing epidemics of type 2 diabetes and obesity. GI Dynamics is committed to leading the way by pioneering a platform of technologies that result in gastric bypass-like resolution of type 2 diabetes and significant weight loss - without invasive surgery.